RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

Regulatory Focus™ > News Articles > Brazil's Anvisa to Open Consultation on Single-Facility Multiple-Product Production

Brazil's Anvisa to Open Consultation on Single-Facility Multiple-Product Production

Posted 19 July 2013 | By Louise Zornoza

Brazil's National Agency for Sanitary Surveillance (Anvisa) will soon open a Public Consultation (No. 26/2013) on a proposal to permit the production of veterinary pharmaceuticals, medical devices, cosmetics and toiletries in the same manufacturing site where human medicines are produced, it has announced.

Anvisa's said the proposal would, in its opinion, bring Brazil into alignment with regulatory policies in most other countries surveyed by the agency. Anvisa noted the need for public feedback on the proposal, given the complexity of the issue with the involvement of multiple regulated product sectors. 

The proposal will be open to public consultation starting 22 July 2013.

ANVISA Proposal

Read all Breaking News from RegLink


Tags: brazil

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.